Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Hemp, Inc HEMP OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
35/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Hemp, Inc (HEMP) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 33/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Financials: revenue is $184,396, +80.8%/yr average growth. Net income is $5M (loss), growing at +11%/yr. Net profit margin is -2973% (negative). Gross margin is 47.6% (+25 pp trend).

Balance sheet: total debt is $31M against $13M equity (Debt-to-Equity (D/E) ratio 2.34, leveraged). Current ratio is 51.48 (strong liquidity). Debt-to-assets is 69.6%. Total assets: $44M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 90/100 (Pass), Past 0/100 (Fail), Health 33/100 (Fail), Moat 43/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

HEMP SharesGrow Score Overview

44/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 90/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 43/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — HEMP

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
90/100
HEMP: +80.8%/yr revenue is, +11%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet HEMP: Debt-to-Equity (D/E) ratio 2.34 (leveraged), Current ratio is 51.48 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
43/100
HEMP: Gross margin is 47.6% (+25 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 43/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
HEMP: Net profit margin is -2973%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.00005-0.0001
Volume82.67K
Avg Volume (30D)1.78M
Market Cap$882.95K
Beta (1Y)7.94
Share Statistics
EPS (TTM)0.00
Shares Outstanding$23.84B
IPO Date2013-02-12
Employees5
CEOGary Perlowin
Financial Highlights & Ratios
Revenue (TTM)$184.4K
Gross Profit$87.84K
EBITDA$192.49K
Net Income$-5.48M
Operating Income$-3.31M
Total Cash$182.27K
Total Debt$30.86M
Net Debt$30.77M
Total Assets$44.35M
Price / Earnings (P/E)-0.3
Price / Sales (P/S)4.79
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS4237032069

Price Chart

Track all markets on TradingView
HEMP
Hemp, Inc ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

CVSI
CVSI
CV Sciences, Inc.
$0.03
-4.62%
 CHNC
CHNC
China Infrastructure Construction Corp.
$0.00
+14.94%
 MCOA
MCOA
Marijuana Company of America, Inc.
$0.00
+0.00%
 USMJ
USMJ
North American Cannabis Holdings, Inc.
$0.00
+0.00%
 MJNA
MJNA
Medical Marijuana, Inc.
$0.00
+0.00%
 CNNA
CNNA
Cann American Corp.
$0.00
+0.00%
 HBRM
HBRM
Herborium Group, Inc.
$0.00
+9,900.00%
 GRCU
GRCU
Green Cures & Botanical Distribution Inc.
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message